Biologically active indolylmethyl-1,3,4-oxadiazoles, 1,3,4-thiadiazoles, 4H-1,3,4-triazoles and 1,2,4-triazines

European Journal of Medicinal Chemistry

Volumn 31, Issue 7-8, 1996, Pages 629-634

  Misra, U ^a   Hitkari, A ^a   Saxena, A K ^a   Gurtu, S ^a   Shanker, K ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

1,2,4 triazine; 4 H 1,3,4 triazole; Antidepressant; Antiinflammatory; Indolmethyl 1,3,4 oxadiazole

Indexed keywords

1,2,4 TRIAZINE DERIVATIVE; 1,3,4 OXADIAZOLE DERIVATIVE; 1,3,4 THIADIAZOLE DERIVATIVE; ANTIDEPRESSANT AGENT; INDOLE DERIVATIVE; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG SYNTHESIS; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; REACTION ANALYSIS; SHORT SURVEY;

EID: 0029814508     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/0223-5234(96)89559-6     Document Type: Article

References (20)

1. 1 Rapport MM, Green AA, Page IH, (1948) Science 108, 329-333
2. 2 Azima H, Arthur A, Silver A, Azima FJ, (1962) Am J Psychiatry 119, 537-540
3. 3 Archer S, Wylie DW, Harris LS et al (1962) J Am Chem Soc 84, 1306-1308
4. 4 Shen TY, Winter CA, Simmonds AB (1977) Advances in Drug Res 12, Academic, NY, 89
5. 5 Shen TY (1965) Non-steroidal anti-inflammatory drugs. Experta Medica Found, New York, 13
6. 6 Bhalla M, Hitkari A, Gujrati VR, Bhalla TN, Shanker K (1994) Eur J Med Chem 29 (9), 713-717
7. 7 Plasica Q (1986) J Med Chem 20, 291-295
8. 8 Singh IP, Saxena AK, Sinha JN, Bhargawa KP, Shanker K (1984) Indian J Chem 23B, 592-594
9. 9 Bhalla M, Srivastava VK, Bhalla TN, Shanker K (1993) Arzneim Forsch 43, 5, 595-600
10. 10 Bullock MW, Fox SW (1951) J Am Chem Soc 73, 5155-5157
11. 11 Shanker K, Agarwal VK, Selveraj RJ, Parmar SS (1969) J Med Chem 12, 324-327
12. 12 Sathi G, Gujrati VR, Nath C, Shanker K (1983) Arzneim Forsch 33, 1218-1221
13. 13 Nodine JH, Eigel RF (1914) Animal and Clinical Pharmacological Techniques in Drug Evaluation, Medical Publishers Inc, Chicago
14. 14 Chessin ME, Kramer ER, Scott CC (1957) J Pharmacol 119, 453-456
15. 15 Rubin B, Malone MH, Wangh MH, Burki JC (1957) J Pharmacol Exp Ther 120, 125-128
16. 16 Everette GM, Darwin JC, Tomen JEP (1959) Fed Proc 18, 338-340
17. 17 Porsolt RD, Asten G, Blaret N, Jaltreen M (1978) Eur J Pharmacol 23, 378-380
18. 18 Swinyard EA, Brown WC, Goodman LS (1962) J Pharmacol Exp Ther 106, 319-322
19. 19 Winter CA, Risley EA, Nuss GW (1962) Proc Soc Exp Biol Med 111, 534-537
20. 20 Buttle CAN, Arcy PFW, Howard EM, Kettel DM (1969) Nature (London) 179, 629-637